Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies.
about
Molecular determinants of species specificity in the coronavirus receptor aminopeptidase N (CD13): influence of N-linked glycosylation.Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infectionSIVsm quasispecies adaptation to a new simian host.The Antibody Response against HIV-1Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and ImmunityLongitudinal study of primary HIV-1 isolates in drug-naïve individuals reveals the emergence of variants sensitive to anti-HIV-1 monoclonal antibodiesAutologous neutralizing antibodies to the transmitted/founder viruses emerge late after simian immunodeficiency virus SIVmac251 infection of rhesus monkeysThe influence of N-linked glycans on the molecular dynamics of the HIV-1 gp120 V3 loop.HIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual.Functional contributions of carbohydrate on AIDS virus glycoproteinHIV-1 envelope subregion length variation during disease progressionEfficient on-chip isolation of HIV subtypesAnimal models for HIV/AIDS researchEvolution of the uniquely adaptable lentiviral envelope in a natural reservoir host.Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways.Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection.Protection of macaques with diverse MHC genotypes against a heterologous SIV by vaccination with a deglycosylated live-attenuated SIV.Limited breadth of the protective immunity elicited by simian immunodeficiency virus SIVmne gp160 vaccines in a combination immunization regimenR5 clade C SHIV strains with tier 1 or 2 neutralization sensitivity: tools to dissect env evolution and to develop AIDS vaccines in primate models.Temporal analysis of HIV envelope sequence evolution and antibody escape in a subtype A-infected individual with a broad neutralizing antibody responseEvolution of the HIV-1 env gene in the Rag2-/- gammaC-/- humanized mouse modelVariants of human immunodeficiency virus type 1 that efficiently use CCR5 lacking the tyrosine-sulfated amino terminus have adaptive mutations in gp120, including loss of a functional N-glycanSelection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels.Location-specific, unequal contribution of the N glycans in simian immunodeficiency virus gp120 to viral infectivity and removal of multiple glycans without disturbing infectivityCharacterization of a macaque recombinant monoclonal antibody that binds to a CD4-induced epitope and neutralizes simian immunodeficiency virusVariants from the diverse virus population identified at seroconversion of a clade A human immunodeficiency virus type 1-infected woman have distinct biological properties.Quintuple deglycosylation mutant of simian immunodeficiency virus SIVmac239 in rhesus macaques: robust primary replication, tightly contained chronic infection, and elicitation of potent immunity against the parental wild-type strain.Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies.Virus isolates during acute and chronic human immunodeficiency virus type 1 infection show distinct patterns of sensitivity to entry inhibitors.Conserved, N-linked carbohydrates of human immunodeficiency virus type 1 gp41 are largely dispensable for viral replication.Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4Human immunodeficiency virus type 1 variants isolated from single plasma samples display a wide spectrum of neutralization sensitivityNeutralization patterns and evolution of sequential HIV type 1 envelope sequences in HIV type 1 subtype B-infected drug-naive individuals.Envelope-modified single-cycle simian immunodeficiency virus selectively enhances antibody responses and partially protects against repeated, low-dose vaginal challengeRelative replication capacity of phenotypic SIV variants during primary infections differs with route of inoculation.Algal lectins as potential HIV microbicide candidatesCharacterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infectionConsistent patterns of change during the divergence of human immunodeficiency virus type 1 envelope from that of the inoculated virus in simian/human immunodeficiency virus-infected macaquesPartial rescue of V1V2 mutant infectivity by HIV-1 cell-cell transmission supports the domain's exceptional capacity for sequence variation.Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.
P2860
Q24529180-190D5C93-7DD8-49CD-859F-18FCC0EB711AQ24538985-BFCA64D8-043E-439D-BEC9-06EEA8F098E2Q24817181-6B57FB0F-48AA-43FE-8FE9-5CEF869D5312Q27000889-1718E891-1D1A-4D74-8278-6F1D11CCAC58Q27654848-26B2491F-F98D-4FC1-B767-0872ACE86EFFQ28477253-7D978D02-469E-43DB-8F0F-469BD5F056B9Q28751926-E05802FF-79AC-4B56-A57D-C3BF128E39EAQ30356350-44221EEA-7475-41D6-B27D-61C55F60516AQ30393763-082C19DE-EF42-4CF4-BE30-D064BD687AAFQ30397572-6EC8043E-26E7-48F9-94DE-F6DEC0FA7781Q30397933-D69B5139-2A0C-40DC-877A-4D7F01E4A0BFQ30413840-0EC00201-BB9B-491B-8D6B-7F1E55C20FE6Q30423656-0C419CC7-6C60-43C1-AF35-9D8C6D9B9559Q31034710-8FE798BA-DFF1-4335-A7C1-DA83BD42953BQ33504599-89E3C299-C5C5-4864-B83A-F0AAFCA8073AQ33504604-B187D76F-79A5-4535-AC2E-00CCDC3818E1Q33638458-E82C38EC-A932-4176-8EF7-D09426244AA0Q33639684-CE5AFC33-0E4B-4FAC-8830-F25908CF449FQ33640144-135BE024-CBFF-49EB-8E53-C6BF01B5FC9EQ33664910-D082B1D5-7D70-4B9E-A57D-8BECA89E1852Q33676640-9A19372B-70B5-481C-8280-62A2F2C825CEQ33707333-EAA5A0D4-89DB-4B5B-A27E-44B177797C8EQ33780649-5EE8A32B-016C-46B1-8AB8-C02D21C40E45Q33785035-0B34A8BC-B3FF-4AD1-8CD2-CD3F3454EBFDQ33809225-D54BA690-8453-4D78-8586-8BEB8286C01BQ33814773-04A260C5-CD1E-45E7-B3B8-C1C7E91813C2Q33839044-5DB9449D-F5DA-4DD9-B546-6D260B10613BQ33840365-75F31EC3-5DD0-4C22-AF83-81A2456D7F4DQ33843345-C386A4C5-FCE0-4B13-A838-76D467382CAEQ33849755-12F24584-5B91-4C58-9196-44E10B103C02Q33851405-9DE1C774-088A-4FD4-93F3-9FB3C21540CEQ33987391-D0560B56-19B7-4DF8-A0C4-BE9A30BD8782Q34085098-14D04942-DC58-4CF3-A50B-B8DA1484C4C2Q34178259-78CF218D-BEDC-4245-9A30-23B9512DF5C8Q34243486-BE38E820-6EFF-441E-B847-0A4FEFBA4174Q34291727-293512FB-FAEC-4E76-9B4B-6AF8462656A9Q34300812-CC33FFD8-3C60-43CD-9197-DAB5863B8027Q34301728-A128F26B-5620-4FF3-98FC-F28FFAC6244DQ34309493-56C299F3-13F8-4D90-9FEC-1F1619A3D3DCQ34349343-2212E7BC-C946-4110-B449-51CA1D820AC1
P2860
Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Specific N-linked and O-linked ...... on by neutralizing antibodies.
@en
type
label
Specific N-linked and O-linked ...... on by neutralizing antibodies.
@en
prefLabel
Specific N-linked and O-linked ...... on by neutralizing antibodies.
@en
P2093
P2860
P921
P1433
P1476
Specific N-linked and O-linked ...... on by neutralizing antibodies.
@en
P2093
B Chackerian
J Overbaugh
L M Rudensey
P2860
P304
P407
P577
1997-10-01T00:00:00Z